Back to Newsroom

Corbus Pharmaceuticals to Host Fireside Chat on Dermatomyositis with Expert Physician and Researcher, Victoria Werth, MD

NORWOOD, MA — (Marketwired) — 08/31/17 — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, announced today that it will host a live video webcast (details below) on Tuesday, September 5, 2017 at 12:00 PM ET to discuss dermatomyositis: the disease, its treatment, and its impact on patients’ lives.